Every successful corporation has a person behind it who is committed to the vision of the corporation and he or she embodies the values and goals of the corporation. Clay Siegall is one such person. Clay Siegall is the co-founder of Seattle Genetics and a distinguished scientist. He is also the company’s president, the chief executive officer and the chairman of the board. He holds a B.S in Zoology from the University of Maryland and a Ph.D. in Genetics from George Washington University. Due to his experience in the scientific field and his innovations at Seattle Genetics, he is well known in the scientific work and he holds several honorary positions.
What sets Mr. Clay Siegall apart in the scientific world is his commitment to research and innovation. Under his leadership, Seattle Genetics has broken several barriers in the field of oncology research. Some of the successes of Seattle Genetics under the leadership of Clay Siegall are; high level financing both from private financiers and public financiers, high profits and ground-breaking scientific innovations. Seattle Genetics is one of the few Oncology Corporations that are listed and they trade in the stock markets.
Seattle Genetics has made ground breaking discovering in oncology research through the innovation ofADCETRIS (brentuximabvedotin) which is a cancer treatment method that was approved in 2011. The company has invested heavily in antibody technologies and it a lead industry player in the area of cancer research. Seattle Genetics has also achieved great success in the scientific world through its collaborations with other industry players. One of the core values of the company is to share its knowledge, resources and experiences with others so as to add value to the world and in particular to those who are affected by cancer.
The company has diverse licenses and this has enabled it to expand at a fast rate and to come up with ground breaking innovations. The company is a publicly listed company since 2001. It has managed to raise 675 Million dollars through public and private financing. The money has been used to intensify research at the company and Seattle Genetics is set to release a wide range of new products in the near future.